Title : S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro.

Pub. Date : 2008 Dec 18

PMID : 18762368






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro. Carboplatin S100 calcium binding protein P Homo sapiens
2 Alternatively, with down-regulation of S100P by siRNA, the IC50 to carboplatin and paclitaxel increased in each case (p<0.05), which was significantly higher compared to untransfected cells. Carboplatin S100 calcium binding protein P Homo sapiens
3 CONCLUSION: Changes in expression levels of S100P in SKOV3 and OVCAR3 cells results in variable susceptibility to carboplatin and paclitaxel. Carboplatin S100 calcium binding protein P Homo sapiens
4 These data suggest that S100P contributes to chemosensitivity to carboplatin and paclitaxel in ovarian cancer cells. Carboplatin S100 calcium binding protein P Homo sapiens